Deciphera Pharmaceuticals, Inc. - stock earnings
DCPH Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 BeforeMarket | - / -0.5500000000 | - | - / 46.3 million | - |
DCPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -47.2 million USD | 48.3 million USD |
| 2023Q3 | -49.6 million USD | 43.3 million USD |
| 2023Q2 | -48.6 million USD | 38.3 million USD |
| 2023Q1 | -49.6 million USD | 33.4 million USD |
| 2022Q4 | -45.9 million USD | 36.3 million USD |
| 2022Q3 | -39.4 million USD | 36.0 million USD |
| 2022Q2 | -41.6 million USD | 32.5 million USD |
| 2022Q1 | -46.1 million USD | 29.2 million USD |
| 2021Q4 | -88.4 million USD | 24.2 million USD |
| 2021Q3 | -79.8 million USD | 23.2 million USD |
| 2021Q2 | -70.4 million USD | 23.6 million USD |
| 2021Q1 | -61.3 million USD | 25.2 million USD |
| 2020Q4 | -62.7 million USD | 19.5 million USD |
| 2020Q3 | -63.7 million USD | 15.4 million USD |
| 2020Q2 | -67.2 million USD | 7.1 million USD |
| 2020Q1 | -72.8 million USD | 62000 USD |
| 2019Q4 | -67.2 million USD | ? USD |
| 2019Q3 | -56.2 million USD | ? USD |
| 2019Q2 | -21.5 million USD | 25.0 million USD |
| 2019Q1 | -47.4 million USD | ? USD |
| 2018Q4 | -32.3 million USD | ? USD |
| 2018Q3 | -24.4 million USD | ? USD |
| 2018Q2 | -21.7 million USD | ? USD |
| 2018Q1 | -21.4 million USD | ? USD |
| 2017Q4 | -19.9 million USD | ? USD |
| 2017Q3 | -12.0 million USD | ? USD |
| 2017Q2 | -10.6 million USD | ? USD |
| 2017Q1 | -7.7 million USD | ? USD |
| 2016Q4 | -8.6 million USD | ? USD |
| 2016Q3 | -6.1 million USD | ? USD |
| 2015Q4 | -19.8 million USD | ? USD |
DCPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -194.9 million USD | 163.4 million USD |
| 2022 | -178.9 million USD | 134.0 million USD |
| 2021 | -296.8 million USD | 96.1 million USD |
| 2020 | -266.5 million USD | 42.1 million USD |
| 2019 | -191.5 million USD | 25.0 million USD |
| 2018 | -99.9 million USD | ? USD |
| 2017 | -50.3 million USD | ? USD |
| 2016 | -25.9 million USD | ? USD |
| 2015 | -19.8 million USD | ? USD |
DCPH
Price: $25.36
52 week price:
Earnings Per Share: -2.29 USD
P/E Ratio: -6.67
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 800800
Ebitda: -12.0 millionMarket Capitalization: 2.1 billion